Anzeige
Meldung des Tages: Gold im Fokus: Warum diese milliardenschwere Goldaktie vom aktuellen Goldumfeld profitieren könnte

ONCOTELIC THERAP. DL-,01 Aktie News

Aktie
WKN:  A14Y0U ISIN:  US6283411097 US-Symbol:  OTLC
0,07247 $
-0,0015 $
-2,07%
0,06144 € 04.02.26
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
-
KGV
-
Index-Zuordnung
-

ONCOTELIC THERAP. DL-,01 News

27.10.25 - PR Newswire
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology PR Newswire
27.10.25 - PR Newswire
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology PR Newswire
17.09.25 - PR Newswire
Advancing Cancer Research Brings New Hope for Patients Worldwide
Advancing Cancer Research Brings New Hope for Patients Worldwide PR Newswire
17.09.25 - PR Newswire
Advancing Cancer Research Brings New Hope for Patients Worldwide
Advancing Cancer Research Brings New Hope for Patients Worldwide PR Newswire
15.09.25 - PR Newswire
Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth
Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth PR Newswire
14.12.21 - EQS
Oncotelic's Dr. Anthony Maida to Present at 2nd Annual TGF-β for Immuno-Oncology Drug Development Summit in January 2022
DGAP-News: Oncotelic Therapeutics Oncotelic's Dr. Anthony Maida to Present at 2nd Annual TGF-β for Immuno-​Oncology Drug Development Summit in January 2022 14.12.2021 / ...
23.11.21 - EQS
ONCOTELIC ANNOUNCES POSITIVE TOPLINE DATA FOR OT-101 C001 COVID STUDY
DGAP-News: Oncotelic Therapeutics ONCOTELIC ANNOUNCES POSITIVE TOPLINE DATA FOR OT-101 C001 COVID STUDY 23.11.2021 / 13:00 The issuer is solely responsible ...

Newssuche

Videos

newspaper
10:20 Uhr +5,17%
Technical Trading: Pfund Short im Februar
GBP/USD Short Typ: Turbo Open End WKN: VH3A2E Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »